Cardiovascular disease is a leading cause of death worldwide. The underlying mechanisms
of most cardiovascular disorders involve innate and adaptive immune responses, and …

Mesenchymal stem cells (MSCs) have gained attention as a promising therapeutic approach
in both preclinical and clinical osteoarthritis (OA) settings. Various joint cell types, such as …

Inflammation is a major underlying mechanism in the progression of numerous
cardiovascular diseases (CVDs). Regulatory T cells (Tregs) are typical immune regulatory …

Cardiovascular diseases (CVDs) are the leading cause of death and disability worldwide.
The CVDs are accompanied by inflammatory progression, resulting in innate and adaptive …

Heart failure (HF), a syndrome of persistent development of cardiac insufficiency due to
various heart diseases, is a serious and lethal disease for which specific curative therapies …

Myocarditis is an inflammatory disease of the myocardium with heterogeneous etiology,
clinical presentation, and prognosis; when it is associated with myocardial dysfunction, this …

Summary Background Pulmonary Arterial Hypertension (PAH) is a progressive condition
with no cure. Even with pharmacologic advances, survival remains poor. Lung pathology on …

Currently, stem cells are a prominent focus of regenerative engineering research. However,
due to the limitations of commonly used stem cell sources, their application in therapy is …

Myocarditis is an inflammatory heart disease that mostly affects young people. Myocarditis
involves a complex immune network; however, its detailed pathogenesis is currently …

Background Infectious pneumonia is one of the important causes of neonatal death that can
lead to the imbalance of T helper 17 cells (Th17) and T regulatory T cells (Treg) cells. The …